Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2022-12-22 00:00:00 ET · period of report 2022-12-20 · accession 0001209191-22-062412 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-22 | 2022-12-20 | ABCL | Booth Andrew | CFO | G - Gift | $0.00 | -50.0K | 138.5K | -27% | $0 |
| D | 2022-12-22 | 2022-12-20 | ABCL | Booth Andrew | CFO | M - OptEx | $0.19 | +50.0K | 188.5K | +36% | +$9,500 |
| D | 2022-12-22 | 2022-12-20 | ABCL | Booth Andrew | CFO | M - OptEx | $0.00 | -50.0K | 5.82M | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2022-12-20 | G | D | 50,000 | $0.00 | 138,500 | D | — | — | (F1) This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022. |
| 2 | Common | Common Shares | 2022-12-20 | M | A | 50,000 | $0.19 | 188,500 | D | — | — | |
| 3 | Derivative | Share option (right to buy) | 2022-12-20 | M | D | 50,000 | $0.00 | 5,820,481 | D | $0.19 · — to 2026-06-15 | 50,000 Common shares | (F2) The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date. |